04/15/2024 3:24 PM | Mineralys Therapeutics (Issuer) Rodman David Malcom (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 11:15 PM | Mineralys Therapeutics (Filer)
| Form EFFECT | |
04/11/2024 3:35 PM | Mineralys Therapeutics (Filer)
| Form 424B5 | |
04/09/2024 6:15 AM | Mineralys Therapeutics (Filer)
| Form DEF 14A | |
04/09/2024 6:18 AM | Mineralys Therapeutics (Filer)
| Form DEFA14A | |
04/09/2024 6:21 AM | Mineralys Therapeutics (Filer)
| Form ARS | |
04/04/2024 7:04 AM | Mineralys Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
03/29/2024 3:44 PM | Mineralys Therapeutics (Filer)
| Form S-3/A | |
03/21/2024 6:43 AM | Mineralys Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/21/2024 6:30 AM | Mineralys Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/21/2024 6:14 AM | Mineralys Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/13/2024 4:35 PM | Mineralys Therapeutics (Issuer) Rodman David Malcom (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:20 PM | Mineralys Therapeutics (Subject) TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
02/14/2024 8:06 PM | Mineralys Therapeutics (Issuer) Samsara BioCapital GP, LLC (Reporting) Samsara BioCapital, L.P. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 8:07 PM | AKKARAJU SRINIVAS (Reporting) Mineralys Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:49 PM | Kolchinsky Peter (Reporting) Mineralys Therapeutics (Issuer) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund III, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:04 AM | ADAMS STREET PARTNERS LLC (Filed by) Mineralys Therapeutics (Subject)
| Form SC 13G | |
02/08/2024 3:41 PM | Mineralys Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/12/2024 3:01 PM | Mineralys Therapeutics (Issuer) Rodman David Malcom (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 8:04 AM | Mineralys Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2023 5:18 PM | Mineralys Therapeutics (Issuer) Rodman David Malcom (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 7:20 AM | Mineralys Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 4:15 PM | Mineralys Therapeutics (Issuer) Rodman David Malcom (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 9:06 AM | Mineralys Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/14/2023 3:11 PM | Mineralys Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/14/2023 3:13 PM | Mineralys Therapeutics (Issuer) SBLENDORIO GLENN (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/14/2023 3:13 PM | Mineralys Therapeutics (Issuer) SBLENDORIO GLENN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/14/2023 3:13 PM | Karydas Daphne (Reporting) Mineralys Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/14/2023 3:14 PM | Karydas Daphne (Reporting) Mineralys Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
09/08/2023 7:49 AM | Congleton Jon (Reporting) Mineralys Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2023 6:11 PM | Congleton Jon (Reporting) Mineralys Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2023 6:11 PM | Mineralys Therapeutics (Issuer) Rodman David Malcom (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/11/2023 3:55 PM | Mineralys Therapeutics (Subject) Rodman David Malcom (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023 5:51 PM | Mineralys Therapeutics (Subject) Rodman David Malcom (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023 3:03 PM | Mineralys Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/14/2023 7:55 AM | Catalys Pacific Fund, LP (Reporting) Mineralys Therapeutics (Issuer) Slingsby Brian Taylor (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/14/2023 7:55 AM | Mineralys Therapeutics (Issuer) Takahashi Takeshi (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2023 7:09 AM | Mineralys Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |